Product Image

Super EPA Pro

Thorne
4.9
★ ★ ★ ★ ★
(382 ratings)
EPA (Eicosapentaenoic Acid) 1300 mg
DHA 320 mg
Product Image
Score76
A potent EPA-specialist formula with clear dosing, but ethyl-ester delivery and premium cost are meaningful trade-offs.
How scoring works
Quantity:120 Gelcap(s) • (60 servings)
Goals:
Heart Health
Mental Focus

Score 76

A potent EPA-specialist formula with clear dosing, but ethyl-ester delivery and premium cost are meaningful trade-offs.
How scoring works
$93.00($1.55 per serving)
Vitacost
$ 93.00
iHerb
$ 93.00
Pure Formulas
$ 93.00
Report prices

Analysis

Two gelcaps supply 1,300 mg EPA and 320 mg DHA. The strongly EPA-led ratio is well suited to users deliberately seeking concentrated EPA support.

Both fatty acids are ethyl esters, which may absorb less efficiently than triglyceride forms unless taken with dietary fat. Explicit contaminant certification and full oxidation-protection details are not consistently supplied.

The serving cost is high, especially for users who do not need this concentration. The formula supports long-term heart and inflammatory pathways but is not an acute mental-focus product.

Who is it for
  • Adults specifically seeking high EPA intake
  • People using omega-threes for targeted cardiovascular support
  • Users able to take the dose with a meal
Best for
  • High-potency EPA support
  • Cardiovascular routines
  • EPA-led inflammatory-balance support

Pros

  • Very high EPA amount
  • EPA and DHA forms are stated
  • Only two gelcaps for a concentrated dose

Cons

  • Ethyl-ester form needs dietary fat for better absorption
  • High serving cost
  • Purity certification is not supplied

Warnings

  • Take with a fat-containing meal
  • High-dose fish oil may increase bleeding tendency with anticoagulants
  • Avoid with a fish allergy

Nutrient quality

85 Highest impact

High EPA and meaningful DHA amounts give the formula strong potency and a clear purpose. The ethyl-ester form is less favorable for absorption than triglyceride oil and needs meal context.

.

Ingredient transparency

83 Highest impact

EPA and DHA amounts and their ethyl-ester forms are explicitly stated without a hidden blend. Fish source, inactive ingredients, oxidation controls, and testing details are not fully disclosed.

.

Customer satisfaction

71 High impact

The aggregate rating is very strong and the review count offers a solid signal. No detailed feedback is supplied to assess recurring tolerability concerns or purpose-specific experience.

.

Value for money

61 Moderate impact

The concentrated EPA dose provides strong functional depth per serving. High serving cost and the less absorbable ethyl-ester form weaken value against premium alternatives.

.
Report analysis

Goals

Heart Health
Impact
Highest effect
A+ Goal FitA Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 1300 mg

The clearly disclosed EPA and DHA amounts provide direct, high-potency support for triglyceride management and cardiovascular inflammation balance. Human evidence for marine omega-3s is strong, especially when the individual fatty acids are supplied at meaningful amounts.

The serving delivers much more EPA than DHA in ethyl-ester form, which suits an EPA-focused lipid strategy. Ethyl esters may absorb less efficiently than triglyceride forms unless taken with a meal containing fat.

Study evidence
Mental Focus
Impact
High effect
C Goal FitB Strength of SupportD+ CoverageB+ Formula Quality

A high EPA amount may support the brain environment through inflammatory-balance and mood pathways, but it is not a direct acute focus enhancer. DHA adds some structural brain support at a lower amount.

Both fatty-acid amounts are clearly stated. The ethyl ester form has lower absorption potential than triglyceride forms, and no alertness, precursor, or stress-resilience ingredient is included.

Study evidence

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Eicosapentaenoic Acid Ethyl Ester
1300 mg
Docosahexaenoic Acid Ethyl Ester
320 mg
Gluten Free Adults 18–50
Report overview
D Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyD+ Value

The serving provides 1300 mg EPA and strongly favors EPA over DHA. EPA is highly concentrated, but the explicitly stated ethyl ester form has lower absorption potential than triglyceride forms. No contaminant certification or oxidation-protection antioxidant is disclosed, and EPA cost efficiency is moderate.

DHA · 320 mg OverallScore53
B Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyF Value

Highly concentrated fish oil provides 320 mg of DHA alongside a much larger EPA dose. Mixed tocopherols protect the oil, though the ethyl-ester form is less absorbable than triglyceride oil. The high serving cost leads to poor DHA-specific value despite the concentrated formula.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  3. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  5. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  6. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  7. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  8. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  9. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)